ZA965367B - A pharmaceutical formulation - Google Patents

A pharmaceutical formulation

Info

Publication number: ZA965367B
Authority: ZA; South Africa
Prior art keywords: pharmaceutical formulation; formulation; pharmaceutical
Prior art date: 1995-07-12

Application number

ZA965367A

Inventor

Thorkild Christensen

Per Balschmidt

Hans Holmegaard Soerensen

Ole Hvilsted Olsen

Lars Thim

Original Assignee

Novo Nordisk As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-07-12

Filing date

1996-06-25

Publication date

1997-01-23

1996-06-25 Application filed by Novo Nordisk As filed Critical Novo Nordisk As

1997-01-23 Publication of ZA965367B publication Critical patent/ZA965367B/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Endocrinology (AREA)
Physical Education & Sports Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Urology & Nephrology (AREA)
Zoology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Orthopedic Medicine & Surgery (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Peptides Or Proteins (AREA)

ZA965367A 1995-07-12 1996-06-25 A pharmaceutical formulation ZA965367B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US88195P	1995-07-12	1995-07-12

Publications (1)

Publication Number	Publication Date
ZA965367B true ZA965367B (en)	1997-01-23

Family

ID=21693419

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA965367A ZA965367B (en)	1995-07-12	1996-06-25	A pharmaceutical formulation

Country Status (14)

Country	Link
EP (1)	EP0837690A1 (en)
JP (1)	JPH11510483A (en)
KR (1)	KR19990028908A (en)
CN (1)	CN1190896A (en)
AU (1)	AU699850B2 (en)
BR (1)	BR9609573A (en)
CA (1)	CA2226553A1 (en)
CZ (1)	CZ6198A3 (en)
HU (1)	HUP9802286A3 (en)
IL (1)	IL122519A0 (en)
NO (1)	NO980103L (en)
PL (1)	PL324386A1 (en)
WO (1)	WO1997002833A1 (en)
ZA (1)	ZA965367B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100236393B1 (en) *	1996-02-02	1999-12-15	나까니시 히로유끼	A pharmaceutical preparation containing a human growth hormone
US6566329B1 (en)	1999-06-28	2003-05-20	Novo Nordisk A/S	Freeze-dried preparation of human growth hormone
MXPA03001092A (en)	2000-08-07	2003-09-25	Nektar Therapeutics Al Corp	Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation.
AU2003289317A1 (en) *	2002-12-11	2004-06-30	Santen Pharmaceutical Co., Ltd.	Preservative for ophthalmology
CN103751769B (en) *	2013-12-25	2015-08-19	楼秀余	A kind of lyophilizing recombinant human somatropin capsule and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4816568A (en) *	1986-05-16	1989-03-28	International Minerals & Chemical Corp.	Stabilization of growth hormones
EP1197222B1 (en) *	1991-12-20	2007-08-01	Novo Nordisk A/S	A stabilized pharmaceutical formulation comprising growth hormone and histidine
DK204791D0 (en) *	1991-12-20	1991-12-20	Novo Nordisk As	UNKNOWN PHARMACEUTICAL PREPARATION
KR19980701351A (en) *	1995-01-13	1998-05-15	슈타르 피아	A STABILIZED PHARMACEUTICAL FORMULATION COMPRISING A GROWTH HORMONE AND X-Lys

1996
- 1996-06-25 ZA ZA965367A patent/ZA965367B/en unknown
- 1996-06-28 KR KR1019980700210A patent/KR19990028908A/en not_active Application Discontinuation
- 1996-06-28 CN CN96195465A patent/CN1190896A/en active Pending
- 1996-06-28 EP EP96922774A patent/EP0837690A1/en not_active Withdrawn
- 1996-06-28 WO PCT/DK1996/000290 patent/WO1997002833A1/en not_active Application Discontinuation
- 1996-06-28 PL PL96324386A patent/PL324386A1/en unknown
- 1996-06-28 CA CA002226553A patent/CA2226553A1/en not_active Abandoned
- 1996-06-28 CZ CZ9861A patent/CZ6198A3/en unknown
- 1996-06-28 AU AU63533/96A patent/AU699850B2/en not_active Ceased
- 1996-06-28 BR BR9609573A patent/BR9609573A/en not_active Application Discontinuation
- 1996-06-28 JP JP9505422A patent/JPH11510483A/en active Pending
- 1996-06-28 IL IL12251996A patent/IL122519A0/en unknown
- 1996-06-28 HU HU9802286A patent/HUP9802286A3/en unknown
1998
- 1998-01-09 NO NO980103A patent/NO980103L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
CA2226553A1 (en)	1997-01-30
NO980103D0 (en)	1998-01-09
AU6353396A (en)	1997-02-10
HUP9802286A2 (en)	1999-02-01
BR9609573A (en)	1999-03-02
CZ6198A3 (en)	1998-06-17
AU699850B2 (en)	1998-12-17
KR19990028908A (en)	1999-04-15
CN1190896A (en)	1998-08-19
HUP9802286A3 (en)	1999-06-28
WO1997002833A1 (en)	1997-01-30
NO980103L (en)	1998-01-09
JPH11510483A (en)	1999-09-14
IL122519A0 (en)	1998-06-15
MX9800309A (en)	1998-07-31
PL324386A1 (en)	1998-05-25
EP0837690A1 (en)	1998-04-29

Publication	Publication Date	Title
ZA965368B (en)	1997-01-14	A pharmaceutical formulation
ZA96124B (en)	1996-08-13	A pharmaceutical formulation
GB9519363D0 (en)	1995-11-22	Pharmaceutical formulation
EG23826A (en)	2007-09-25	Pharmaceutical formulations
GB9523752D0 (en)	1996-01-24	Pharmaceutical formulations
GB9407386D0 (en)	1994-06-08	Pharmaceutical formulation
GB9402203D0 (en)	1994-03-30	Pharmaceutical formulation
IL112521A0 (en)	1995-05-26	Pharmaceutical formulation
EP0862431A4 (en)	1999-07-07	Pharmaceutical formulation
ZA958606B (en)	1996-05-14	A pharmaceutical formulation
GB9405856D0 (en)	1994-05-11	Pharmaceutical formulation
GB9416599D0 (en)	1994-10-12	Pharmaceutical formulation
GB9523566D0 (en)	1996-01-17	Pharmaceutical formulation
ZA96526B (en)	1996-08-06	Novel pharmaceutical formulation
AU3949093A (en)	1993-11-08	A pharmaceutical formulation
ZA964372B (en)	1996-12-05	A pharmaceutical formulation
ZA965367B (en)	1997-01-23	A pharmaceutical formulation
AP9801196A0 (en)	1998-03-31	Pharmaceutical preparation
ZA96122B (en)	1996-07-24	A pharmaceutical formulation
HU9603498D0 (en)	1997-02-28	Pharmaceutical compounds
ZA96392B (en)	1996-08-29	Pharmaceutical formulations
ZA96123B (en)	1996-07-30	A pharmaceutical formulation
GB9500978D0 (en)	1995-03-08	Pharmaceutical formulations
GB9502786D0 (en)	1995-04-05	Pharmaceutical formulation
GB9525386D0 (en)	1996-02-14	Pharmaceutical formulation